Astria Therapeutics
ATXS
ATXS
23 hedge funds and large institutions have $10.5M invested in Astria Therapeutics in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Holders
23
Holding in Top 10
1
Calls
$4.37M
Puts
–
Top Buyers
| 1 | +$878K | |
| 2 | +$281K | |
| 3 | +$147K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$50K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14K |
Top Sellers
| 1 | -$764K | |
| 2 | -$584K | |
| 3 | -$136K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$72K |
| 5 |
Millennium Management
New York
|
-$66K |